These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Zinc in patients with chronic renal insufficiency subjected to extrarenal depuration technics by peritoneal dialysis]. Temes Montes XL; Herrero E; Picaporte MA; Sánchez-Guisande D; Otero A; Sánchez-Sicilia L Rev Clin Esp; 1982 May; 165(3):193-4. PubMed ID: 7134532 [No Abstract] [Full Text] [Related]
26. Amphotericin B does not increase peritoneal fluid removal. Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B Adv Perit Dial; 1998; 14():3-10. PubMed ID: 10649681 [TBL] [Abstract][Full Text] [Related]
27. Serum and peritoneal fluid amylase levels in CAPD. Normal values and clinical usefulness. Caruana RJ; Burkart J; Segraves D; Smallwood S; Haymore J; Disher B Am J Nephrol; 1987; 7(3):169-72. PubMed ID: 2443007 [TBL] [Abstract][Full Text] [Related]
28. Effect of chronic peritoneal fluid eosinophilia on peritoneal membrane function. Ejaz AA; Zabaneh RI; Ridlon T; Durkin W; Siddiqui T J Pak Med Assoc; 1998 Aug; 48(8):233-4. PubMed ID: 10067037 [TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of protein content in rat mesenteric tissue, peritoneal fluid, and plasma. Barber BJ; Schultz TJ; Randlett DL Am J Physiol; 1990 May; 258(5 Pt 1):G714-8. PubMed ID: 2333999 [TBL] [Abstract][Full Text] [Related]
30. Inhibitors of lymphocyte activity in peritoneal fluid of continuous ambulatory peritoneal dialysis (CAPD). Giangrande A; Cantù P; De Francesco D; Limido A Clin Nephrol; 1984 Jul; 22(1):52-3. PubMed ID: 6478664 [No Abstract] [Full Text] [Related]
31. [Selection of the optimal method of evaluation of peritonitis risk in patients treated by standard peritoneal dialysis]. Smoszna J; Raczka A; Fuksiewicz A; Wańkowicz Z Pol Arch Med Wewn; 1989 Feb; 81(2):92-9. PubMed ID: 2616362 [TBL] [Abstract][Full Text] [Related]
32. Peritoneal dialysis in a 6-weeks old preterm infant with severe theophylline intoxication. Colonna F; Trappan A; de Vonderweid U; Nisi G Minerva Pediatr; 1996 Sep; 48(9):383-5. PubMed ID: 8968151 [TBL] [Abstract][Full Text] [Related]
33. Inhibitors of lymphocyte activity in peritoneal fluid of continuous ambulatory peritoneal dialysis (CAPD). Giangrande A; Cantù P; De Francesco D; Limido A Int J Artif Organs; 1984 Mar; 7(2):63-6. PubMed ID: 6735497 [No Abstract] [Full Text] [Related]
34. Net ultrafiltration in peritoneal dialysis: role of direct fluid absorption into peritoneal tissue. Flessner MF Blood Purif; 1992; 10(3-4):136-47. PubMed ID: 1308680 [TBL] [Abstract][Full Text] [Related]
36. In vitro simulations of peritoneal dialysis. A technique for demonstrating limitations on solute clearances due to stagnant fluid films and poor mixing. McGary TJ; Nolph KD; Rubin J J Lab Clin Med; 1980 Jul; 96(1):148-57. PubMed ID: 7391655 [TBL] [Abstract][Full Text] [Related]
38. Lactic acid concentration in peritoneal fluid of normal and diseased horses. Moore JN; Traver DS; Turner MF; White FJ; Huesgen JG; Butera TS Res Vet Sci; 1977 Jul; 23(1):117-8. PubMed ID: 905642 [TBL] [Abstract][Full Text] [Related]
39. Milky appearance of peritoneal fluid in a neonate on peritoneal dialysis due to end-stage renal disease: Questions. Wu X; Vega M; Swartz SJ; Michael M Pediatr Nephrol; 2018 Jan; 33(1):71-72. PubMed ID: 28283761 [No Abstract] [Full Text] [Related]
40. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Williams JD; Topley N; Craig KJ; Mackenzie RK; Pischetsrieder M; Lage C; Passlick-Deetjen J; Kidney Int; 2004 Jul; 66(1):408-18. PubMed ID: 15200450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]